Boothbay Fund Management »

Tarsus Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.1M 276k 32.89
2024-06-30 $5.4M 200k 27.18
2024-03-31 $7.3M 200k 36.35
2023-09-30 $2.0M 112k 17.77

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dell Technologies CL C Call Option (DELL)
Select Sector Spdr Tr Indl Put Option (XLI)
Cornerstone Strategic Value (CLM)
NVIDIA Corporation Put Option (NVDA)
Take-Two Interactive Software (TTWO)
Sba Communications Corp Cl A (SBAC)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Netflix (NFLX)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Elanco Animal Health Call Option (ELAN)
Amphenol Corp Cl A (APH)
Western Digital Call Option (WDC)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Equinix (EQIX)

View all positions for Boothbay Fund Management

Top funds holding Tarsus Pharmaceuticals

BlackRock
Rtw Investments
Jennison Associates
Paradigm Biocapital Advisors
Tang Capital Management
Cowen And Company
Vanguard Group
Frazier Life Sciences Management
Perceptive Advisors
Assenagon Asset Management
Ikarian Capital
State Street Corporation
ExodusPoint Capital Management
Geode Capital Management
Artisan Partners Limited Partnership

View all funds holding Tarsus Pharmaceuticals